Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial

被引：0
|
作者：
Chloé Laurencin
Noémie Timestit
Ana Marques
Domitille Dilly Duchez
Caroline Giordana
Sara Meoni
Marine Huddlestone
Teodor Danaila
Mathieu Anheim
Hélène Klinger
Tiphaine Vidal
Marion Fatisson
Catherine Caire
Mikail Nourredine
Philippe Boulinguez
Carole Dhelens
Bénédicte Ballanger
Stéphane Prange
Sylvie Bin
Stéphane Thobois
机构：
[1] Pierre Wertheimer Neurological Hospital,Department of Neurology C, Expert Parkinson Centre, Hospices Civils de Lyon
[2] Hôpital Neurologique Pierre Wertheimer,Lyon Neuroscience Research Centre
[3] INSERM,Department of Biostatistics
[4] University of Lyon,Department of Neurology
[5] University Hospital of Lyon,Department of Neurology
[6] Clermont-Ferrand University Hospital,Department of Neurology
[7] University Hospital of Saint-Etienne,Movement Disorders Unit, Department of Neurology
[8] University Hospital of Nice,Department of Neurology
[9] University Hospital of Grenoble,Pharmacotoxicology Laboratory, Department of Clinical Research and Epidemiology
[10] Strasbourg University Hospital,Pharmacy, FRIPHARM
[11] University Hospital of Lyon,Public Health Center, Research and Clinical Epidemiology
[12] Edouard Herriot Hospital,Faculté de Medecine Et de Maieutique Lyon Sud Charles Mérieux
[13] Lyon University Hospital,Institut de Génétique Et de Biologie Moléculaire Et Cellulaire (IGBMC)
[14] University Hospital of Lyon,Centre de Référence Des Maladies Neurogénétiques Rares, Fédération de Médecine Translationnelle de Strasbourg (FMTS)
[15] Marc Jeannerod Cognitive Neuroscience Institute,undefined
[16] Université Claude Bernard Lyon 1,undefined
[17] Université de Lyon,undefined
[18] INSERM-U964/CNRS,undefined
[19] UMR7104/Strasbourg University,undefined
[20] Université de Strasbourg,undefined
来源：
Journal of Neurology | 2023年 / 270卷
关键词：
Clonidine; Noradrenergic system; Parkinson’s disease; Impulse control disorder; QUIP-RS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4851 / 4859
页数：8
相关论文
共 50 条
  • [21] Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety
    Perez, Evans R. Fernandez
    Crooks, James L.
    Lynch, David A.
    Humphries, Stephen M.
    Koelsch, Tilman L.
    Swigris, Jeffrey J.
    Solomon, Joshua J.
    Mohning, Michael P.
    Groshong, Steve D.
    Fier, Kaitlin
    THORAX, 2023, 78 (11) : 1097 - 1104
  • [22] Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial
    Howard E. Gendelman
    Yuning Zhang
    Pamela Santamaria
    Katherine E. Olson
    Charles R. Schutt
    Danish Bhatti
    Bhagya Laxmi Dyavar Shetty
    Yaman Lu
    Katherine A. Estes
    David G. Standaert
    Elizabeth Heinrichs-Graham
    LuAnn Larson
    Jane L. Meza
    Matthew Follett
    Erica Forsberg
    Gary Siuzdak
    Tony W. Wilson
    Carolyn Peterson
    R. Lee Mosley
    npj Parkinson's Disease, 3
  • [23] Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial
    Gendelman, Howard E.
    Zhang, Yuning
    Santamaria, Pamela
    Olson, Katherine E.
    Schutt, Charles R.
    Bhatti, Danish
    Shetty, Bhagya Laxmi Dyavar
    Lu, Yaman
    Estes, Katherine A.
    Standaert, David G.
    Heinrichs-Graham, Elizabeth
    Larson, Luann
    Meza, Jane L.
    Follett, Matthew
    Forsberg, Erica
    Siuzdak, Gary
    Wilson, Tony W.
    Peterson, Carolyn
    Mosley, R. Lee
    NPJ PARKINSONS DISEASE, 2017, 3
  • [24] Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ) : an international, randomised, double-blind, phase 2b trial
    Bosch-Nicolau, Pau
    Fernandez, Marisa L.
    Sulleiro, Elena
    Villar, Juan Carlos
    Perez-Molina, Jose A.
    Correa-Oliveira, Rodrigo
    Sosa-Estani, Sergio
    Sanchez-Montalva, Adridn
    Bangher, Maria del Carmen
    Moreira, Otacilio C.
    Salvador, Fernando
    Ferreira, Ariela Mota
    Eloi-Santos, Silvana Maria
    Serre-Delcor, Nuria
    Ramirez, Juan Carlos
    Silgado, Aroa
    Oliveira, Ines
    Martin, Oihane
    Aznar, Maria Luisa
    Ribeiro, Antonio Luiz P.
    Almeida, Paulo Emilio Clementino
    Chamorro-Tojeiro, Sandra
    Espinosa-Pereiro, Juan
    de Paula, Alfredo Mauricio Batista
    Vaquiro-Herrera, Eliana
    Tur, Carmen
    Molina, Israel
    LANCET INFECTIOUS DISEASES, 2024, 24 (04): : 386 - 394
  • [25] Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial
    Pinazo, Maria-Jesus
    Forsyth, Colin
    Losada, Irene
    Esteban, Elena Trigo
    Garcia-Rodriguez, Magdalena
    Villegas, Maria Luz
    Molina, Israel
    Crespillo-Andujar, Clara
    Gallego, Montserrat
    Ballart, Cristina
    Ramirez, Juan Carlos
    Aden, Tilman
    Hoerauf, Achim
    Pfarr, Kenneth
    Vaillant, Michel
    Marques, Tayna
    Fernandes, Jayme
    Blum, Bethania
    Ribeiro, Isabela
    Sosa-Estani, Sergio
    Barreira, Fabiana
    Gascon, Joaquim
    LANCET INFECTIOUS DISEASES, 2024, 24 (04): : 395 - 403
  • [26] EFFICACY AND SAFETY OF MOCLOBEMIDE COMPARED WITH MAPROTILINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDER - A DOUBLE-BLIND MULTICENTER STUDY WITH PARALLEL GROUPS
    STEINMEYER, EM
    VORBACH, EU
    ARNOLDT, KH
    PHARMACOPSYCHIATRY, 1993, 26 (06) : 246 - 253
  • [27] Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial
    Feigl, Beatrix
    Lewis, Simon J. G.
    Burr, Lucy D.
    Schweitzer, Daniel
    Gnyawali, Subodh
    Vagenas, Dimitrios
    Carter, Drew D.
    Zele, Andrew J.
    ECLINICALMEDICINE, 2024, 69
  • [28] Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
    Cope, Andrew P.
    Jasenecova, Marianna
    Vasconcelos, Joana C.
    Filer, Andrew
    Raza, Karim
    Qureshi, Sumera
    D'Agostino, Maria Antonietta
    Mcinnes, Iain B.
    Isaacs, John
    Pratt, Arthur G.
    Fisher, Benjamin A.
    Buckley, Christopher
    Emery, Paul
    Ho, Pauline
    Buch, Maya H.
    Ciurtin, Coziana
    van Schaardenburg, Dirkjan
    Huizinga, Thomas
    Toes, Rene
    Georgiou, Evangelos
    Kelly, Joanna
    Murphy, Caroline
    Prevost, A. Toby
    LANCET, 2024, 403 (10429): : 838 - 849
  • [29] Efficacy and Safety of Mulberry Twig Alkaloids Tablet for the Treatment of Type 2 Diabetes: A Multicenter, Randomized, Double-Blind, Double-Dummy, and Parallel Controlled Clinical Trial
    Qu, Ling
    Liang, Xiaochun
    Tian, Guoqing
    Zhang, Gaili
    Wu, Qunli
    Huang, Xiumei
    Cui, Yazhong
    Liu, Yuling
    Shen, Zhufang
    Xiao, Changqing
    Qin, Yingfen
    Miao, Heng
    Zhang, Yongyan
    Li, Ziling
    Ye, Shandong
    Zhang, Xuezhi
    Yang, Jing
    Cao, Guiwen
    Li, Yi
    Yang, Gangyi
    Hu, Ji
    Wang, Xiaoyue
    Li, Zhengfang
    Li, Yukun
    Zhang, Xiuzhen
    Zhang, Guangde
    Chen, Li
    Hua, Wenjin
    Yu, Ming
    Lu, Chunyan
    Zhang, Xiaomei
    Jiang, Hong
    DIABETES CARE, 2021, 44 (06) : 1324 - 1333
  • [30] Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
    Tepper, Stewart
    Ashina, Messoud
    Reuter, Uwe
    Brandes, Jan L.
    Dolezil, David
    Silberstein, Stephen
    Winner, Paul
    Leonardi, Dean
    Mikol, Daniel
    Lenz, Robert
    LANCET NEUROLOGY, 2017, 16 (06): : 425 - 434
12345